Second Generation Tyrosine Kinase Inhibitors and Their Toxicity in Treatment of Patients in Chronic Phase of Chronic Myeloid Leukemia
Background & Aims. Certain experience in the use of new tyrosine kinase inhibitors (TKIs) in treatment of patients with chronic myeloid leukemia has been obtained over the last years. The article summarizes literature data on toxicity obtained in international clinical trials. The aim of the study i...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
Practical Medicine Publishing House
2015-07-01
|
| סדרה: | Клиническая онкогематология |
| נושאים: | |
| גישה מקוונת: | https://bloodjournal.ru/index.php/coh/article/view/554 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|